Results 131 to 140 of about 34,375 (153)

Feasibility of <i>TP53</i>-Mutated ctDNA Monitoring in High-Grade Endometrial Cancer Using Routine NGS. [PDF]

Cancers (Basel)
Marlin R, Jean-Laurent M, Joachim C, Vallard A, Pennont S, Suez-Panama V, Rose M, Ulric-Gervaise S, Lusbec S, Bera O, Aline-Fardin A, Ebring C.   +11 more
europepmc   +1 more source

Real-world analysis of HER2-ultralow in HR+/HER2- metastatic breast cancer: prevalence and first-line chemotherapy outcomes. [PDF]

Ther Adv Med Oncol
Mathiot L, Kerdraon O, Le Borgne F, Verriele V, Patsouris A, Robert M, Chetritt J, Loussouarn D, Campone M, Bocquet F, Frenel JS.   +10 more
europepmc   +1 more source

Chemotherapy-free combination strategies in recurrent platinum-resistant ovarian cancer: promise, evidence and perspectives. [PDF]

Transl Cancer Res
Corbaux P, Freyer G.
europepmc   +1 more source

Stage I placental site trophoblastic tumor with complete response after pembrolizumab. [PDF]

Gynecol Oncol Rep
Descargues P, Eiriksson LR, Rousset P, Msika A, You B, Trecourt A, Massardier J, Hajri T, Borghese B, Golfier F, Bolze PA, Alexandre J.   +11 more
europepmc   +1 more source

Sarcopenia Predicts Mortality in Bladder Cancer with Neoadjuvant Chemotherapy: A Multicenter Study. [PDF]

Cancers (Basel)
Pitout A, Mazeaud C, Blondeau A, Salleron J, Massard V, Lambert A.   +5 more
europepmc   +1 more source

Proposed strategy after complete LAMN (low-grade appendiceal mucinous neoplasm) resection by different RENAPE units: need for a new consensus? [PDF]

Pleura Peritoneum
Mouawad C, Taibi A, Sgarbura O, Djelil D, Marchal F, Sourrouille I, Goere D, Glehen O, Ferron G, Dumont F, Courvoisier Clement T, Brigand C, Amroun KL, Abboud K, Villeneuve L, Pocard M, RENAPE Group.   +16 more
europepmc   +1 more source

Nocardia vinacea infection with septic articular involvement and tenosynovitis. [PDF]

BMC Infect Dis
Tabary A, Dumitrescu O, Hodille E, Fillit CT, Confavreux CB, Massy E.   +5 more
europepmc   +1 more source

Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection of <i>IDH</i> Variants in Solid Tumors and Hematological Malignancies. [PDF]

Int J Mol Sci
Gilson P, Muller M, Gauchotte G, Fadil S, Husson M, Hanriot I, Witz A, Dardare J, Betz M, Merlin JL, Harlé A.   +10 more
europepmc   +1 more source

A survey of practice patterns for patient-specific quality assurance on behalf of the ESTRO dosimetry & quality assurance focus group. [PDF]

Phys Imaging Radiat Oncol
Dufreneix S, Essers M, Aspradakis MM, Wegener S, Saez J, Ventura T, Jornet N, Gerskevitsh E.   +7 more
europepmc   +1 more source